Literature DB >> 9423858

Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain.

E Isogai1, H Isogai, K Kimura, S Hayashi, T Kubota, N Fujii, K Takeshi.   

Abstract

Gnotobiotic mice inoculated with an enterohemorrhagic Escherichia coli (EHEC) O157:H7 strain developed a flaccid paresis, usually culminating in death. The bacteria colonized feces at 10(9) to 10(10) CFU per g (inoculum size: 2.0 x 10(9) CFU/mouse), and Shiga-like toxins (SLTs) were detected in the feces. A microscopic examination of colons showed mild inflammatory cell infiltration, thinning of the intestinal wall, or necrotic foci. Necrosis of tubular cells was noted in these symptomatic mice. Microhemorrhage, thrombosis, and edematous changes of the brain were also seen. Inflammatory cytokines, tumor necrosis factor alpha (TNF-alpha), interleukin 1alpha (IL-1alpha), and IL-6, were detected in the kidney after EHEC infection, but not in the serum. In the brain, only TNF-alpha was detected. When 2.0 x 10(2) CFU of EHEC O157:H7 was fed to germ-free mice, the number of bacteria began to rise rapidly on day 1 and was maintained at 10(8)to 10(9) CFU/g of feces. SLTs were detected in the feces of the mice. However, the mice showed no histological changes and no cytokine responses, similar to what was found for controls. Treatment with TNF-alpha modified the clinical neural signs, histopathological changes, and cytokine responses; mice treated with TNF-alpha developed severe neurotoxic symptoms and had higher frequencies of systemic symptoms and glomerular pathology. Strong cytokine responses were seen in the kidney and brain. Serum cytokines were also detected in this group. In contrast, a TNF-alpha inhibitor (protease inhibitor) inhibited these responses, especially in the brain. However, local synthesis of the cytokines was observed in the kidney. Thus, TNF-alpha and the other proinflammatory cytokines could be important in modifying the disease caused by EHEC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9423858      PMCID: PMC107877     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

Review 1.  The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.

Authors:  P M Griffin; R V Tauxe
Journal:  Epidemiol Rev       Date:  1991       Impact factor: 6.222

2.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

Authors:  J Fujii; T Kita; S Yoshida; T Takeda; H Kobayashi; N Tanaka; K Ohsato; Y Mizuguchi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

3.  Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

4.  Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.

Authors:  N C van de Kar; L A Monnens; M A Karmali; V W van Hinsbergh
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

5.  A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.

Authors:  Y Harel; M Silva; B Giroir; A Weinberg; T B Cleary; B Beutler
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

6.  Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model.

Authors:  S W Lindgren; A R Melton; A D O'Brien
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

7.  Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.

Authors:  V L Tesh; B Ramegowda; J E Samuel
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  In vivo induction of apoptosis and immune responses in mice by administration of lipopolysaccharide from Porphyromonas gingivalis.

Authors:  E Isogai; H Isogal; K Kimura; N Fujii; S Takagi; K Hirose; M Hayashi
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines.

Authors:  B Ramegowda; V L Tesh
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Investigation of enterohemorrhagic Escherichia coli O157:H7 adherence characteristics and invasion potential reveals a new attachment pattern shared by intestinal E. coli.

Authors:  M L McKee; A D O'Brien
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more
  25 in total

1.  Shiga Toxin-Producing Escherichia coli.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Strain-dependent cellular immune responses in cattle following Escherichia coli O157:H7 colonization.

Authors:  Alexander Corbishley; Nur Indah Ahmad; Kirsty Hughes; Michael R Hutchings; Sean P McAteer; Timothy K Connelley; Helen Brown; David L Gally; Tom N McNeilly
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

3.  Effect of enterohaemorrhagic Escherichia coli O157:H7-specific enterohaemolysin on interleukin-1β production differs between human and mouse macrophages due to the different sensitivity of NLRP3 activation.

Authors:  Yu-Li Cheng; Li-Qiong Song; Yuan-Ming Huang; Yan-Wen Xiong; Xiao-Ai Zhang; Hui Sun; Xin-Ping Zhu; Guang-Xun Meng; Jian-Guo Xu; Zhi-Hong Ren
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

4.  The hemorrhagic coli pilus (HCP) of Escherichia coli O157:H7 is an inducer of proinflammatory cytokine secretion in intestinal epithelial cells.

Authors:  Maria A Ledesma; Sara A Ochoa; Ariadnna Cruz; Luz M Rocha-Ramírez; Jaime Mas-Oliva; Carlos A Eslava; Jorge A Girón; Juan Xicohtencatl-Cortes
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

5.  Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1.

Authors:  Lisa M Harrison; Wilhelmina C E van Haaften; Vernon L Tesh
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 6.  Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Ramon Alfonso Exeni; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Gabriela Alejandra Fiorentino; Andrea Mariana Exeni; Maria Victoria Ramos; Marina Sandra Palermo
Journal:  Pediatr Nephrol       Date:  2018-01-25       Impact factor: 3.714

7.  A novel murine infection model for Shiga toxin-producing Escherichia coli.

Authors:  Emily M Mallick; Megan E McBee; Vijay K Vanguri; Angela R Melton-Celsa; Katherine Schlieper; Brad J Karalius; Alison D O'Brien; Joan R Butterton; John M Leong; David B Schauer
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

8.  Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits.

Authors:  M Ogawa; K Shimizu; K Nomoto; M Takahashi; M Watanuki; R Tanaka; T Tanaka; T Hamabata; S Yamasaki; Y Takeda
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

9.  Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora.

Authors:  Krystle L Mohawk; Angela R Melton-Celsa; Tonia Zangari; Erica E Carroll; Alison D O'Brien
Journal:  Microb Pathog       Date:  2010-01-22       Impact factor: 3.738

10.  Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice.

Authors:  Kathryn A Eaton; David I Friedman; Gayle J Francis; Jessica S Tyler; Vincent B Young; Jennifer Haeger; Galeb Abu-Ali; Thomas S Whittam
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.